Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymosin-alpha-1

Thymalfasin, Zadaxin, Thymosin α1

Quick Stats
Studies 759
Trials 63
Score 1
1991 pubmed

Characterization of thymosin alpha 1 and beta 4 during the bovine estrual period: effects of elevated estradiol and progestin.

Wise. T T; Maurer. R R RR

Key Findings

  • Thymosin‑beta‑4 levels vary over the estrous cycle but are not affected by FSH‑induced superovulation despite a ten‑fold rise in estradiol
  • Both thymosin‑alpha‑1 and thymosin‑beta‑4 increase as the estrous period advances and decrease after the LH surge
  • In cows given a progesterone implant to block the LH surge, the hormone‑driven changes in thymosin levels were still observed

Practical Outcomes

  • For most biohackers, the findings are not directly actionable because they come from a cattle reproductive model. The data suggest that natural hormone fluctuations can influence thymosin levels, but there’s no clear protocol or dosage guidance for humans.

Summary

The study measured two thymosin peptides in cows during their reproductive cycle and found that both thymosin‑alpha‑1 and thymosin‑beta‑4 naturally rise as the estrous cycle progresses and fall after the LH surge, while artificially boosting ovary activity with FSH didn’t change beta‑4 levels despite higher estradiol.

Abstract

At present, there is a renewed interest in thymic function and its secretions in relation to endocrine control and reproductive function. In an initial experiment, 60 crossbred heifers (18-20 mo) were detected in estrus and assigned to control or FSH superovulatory groups. On Days 7-14 of the subsequent estrous cycle, FSH was administered for 5 days and prostaglandin F2 alpha (PGF2 alpha) was administered at 48 and 60 h after the initial FSH injection. Control animals received only PGF2 alpha injections between Days 9 and 15 of the cycle. Blood samples were collected from all animals at the time of PGF2 alpha injection and every 12 h thereafter to 72 h post PGF2 alpha injection. In a subsequent experiment, 103 crossbred heifers (16-18 mo) were superovulated with FSH and synchronized to estrus with PGF2 alpha administered 60 h after the initial FSH injection. Twenty-eight of the heifers received Norgestomet implants 12 h prior to the initial PGF2 alpha injection to inhibit the LH surge. Blood samples were collected from animals at 12-h intervals until the PGF2 alpha injection and every 6 h thereafter until 108 h post PGF2 alpha treatment. Although thymosin beta 4 concentrations did change over the estrual period, no differences were noted between control and superovulatory animals in the initial experiment even though estradiol concentrations were increased tenfold from the FSH stimulated ovary. In the second experiment, thymosin beta 4 and alpha 1 increased as the estrual period progressed and decreased (p less than 0.05) subsequent to the LH surge. (ABSTRACT TRUNCATED AT 250 WORDS)

Study Information

Provider

pubmed

Year

1991

DOI

10.1095/biolreprod45.1.57